Related Experiment Video
Updated: May 15, 2026

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
Published on: November 29, 2024
Cardiovascular effects of anti-diabetic medications in type 2 diabetes mellitus
Samar Singh1, Jyoti Bhat, Ping H Wang
1Center for Diabetes Research and Treatment, University of California, Irvine, 92697, USA. samars@uci.edu
Abstract:
Over the past several years, there have been a significant number of new agents developed for the treatment of type 2 diabetes. Our goal in this article is to review the cardiovascular effects (risks and benefits) of these oral and non-insulin injectable agents. We review six major categories of diabetic therapies: biguanides, sulfonylureas, alpha-glucosidase inhibitors, thiazolidinediones, GLP-1 agonists, and DPP-IV inhibitors. In order to achieve a personalized regimen that aims for optimal outcomes, we must take into consideration each drug's side effects, patients' cardiovascular risk factors, and their individual health profile.
Related Concept Videos
Type II Diabetes II: Pathophysiology
Diabetes Mellitus: Type 2 and Gestational
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
Oral Hypoglycemic Agents: Biguanides and Glitazones
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

